
Biotech CEO predicts ‘revolutionary’ steps toward curing cancer on horizon thanks to AI
SELLAS Life Sciences CEO Angelos Stergiou says his company is already on the cusp of a finalized leukemia vaccine, but another game-changer – personalized cancer vaccines – could be on the horizon, thanks to artificial intelligence. “I think it’s going to be a revolutionary decade in medicine and in clinical research,” he said Thursday on…